Showing results (11-20 of 73) with videos related to
Sort By:
Pageof 8
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 24, 2019
Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30<sup>-</sup> TumorsAndreas A Hombach, Gunter Rappl, Hinrich AbkenFrontiers in Immunology|November 26, 2013
Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T CellsMarkus Chmielewski, Andreas A Hombach, Hinrich AbkenCurrent Molecular Medicine|November 3, 2012
The weal and woe of costimulation in the adoptive therapy of cancer with chimeric antigen receptor (CAR)-redirected T cellsA A Hombach, A Holzinger, H AbkenImmunological Reviews|December 17, 2013
Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stromaMarkus Chmielewski, Andreas A Hombach, Hinrich AbkenMolecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2013
Arming cytokine-induced killer cells with chimeric antigen receptors: CD28 outperforms combined CD28-OX40 "super-stimulation"Andreas A Hombach, Gunter Rappl, Hinrich AbkenHybridoma|April 22, 1999
Grafting T cells with tumor specificity: the chimeric receptor strategy for use in immunotherapy of malignant diseasesA Hombach, C Pohl, U Reinhold, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 25, 2000
A novel strategy in the elimination of disseminated melanoma cells: chimeric receptors endow T cells with tumor specificityH Abken, A Hombach, C Heuser, et al.Human Gene Therapy|January 29, 2013
Adoptive immunotherapy with redirected T cells produces CCR7- cells that are trapped in the periphery and benefit from combined CD28-OX40 costimulationAndreas A Hombach, Markus Chmielewski, Gunter Rappl, et al.Gene Therapy|July 1, 2016
A dual chain chimeric antigen receptor (CAR) in the native antibody format for targeting immune cells towards cancer cells without the need of an scFvE Faitschuk, V Nagy, A A Hombach, et al.Gene Therapy|June 26, 2009
Redirecting human CD4+CD25+ regulatory T cells from the peripheral blood with pre-defined target specificityA A Hombach, D Kofler, G Rappl, et al.Pageof 8